Skip to main content
. 2021 Jan 15;13(1):372–382.

Table 3.

A summary of metabolites distinguishing the EAD from the non-EAD group on postoperative day 1 (VIP >1 and p-value <0.05)

ID Adduct EAD (N = 23) Non-EAD (N = 51) p-value VIP
Betaine M+H 7286.22 ± 5287.27 4738.75 ± 1738.33 0.0002 4.57
Palmitic acid (C16:0) M-H 458.96 ± 297.70 297.00 ± 231.01 0.0001 2.18
Oleic acid (C18:1) M-H 2470.17 ± 1959.52 1555.71 ± 1783.92 0.0007 4.60
LysoPC (16:0) M+H 861.00 ± 683.70 1454.67 ± 721.06 <0.0001 2.28
PC (16:0/16:1) M+H 4029.76 ± 1719.00 2850.05 ± 1237.37 <0.0001 3.22
PC (16:0/16:0) M+H 10269.97 ± 4303.20 6959.97 ± 2268.48 <0.0001 5.99
PC (16:0/20:5) M+H 1903.41 ± 980.02 2906.62 ± 1996.07 <0.0001 2.50
PC (16:0/20:4) M+H 43859.61 ± 13800.01 52715.85 ± 19138.16 0.0001 6.96
PC (16:0/22:6) M+H 19410.38 ± 5771.54 27480.17 ± 12769.92 <0.0001 7.90
PC (18:0/20:5) M+H 499.05 ± 424.38 1065.36 ± 997.00 <0.0001 2.00
PC (16:0/22:5) M+H 5017.37 ± 1245.70 5773.87 ± 1391.83 0.0001 2.15
PC (18:0/22:6) M+H 5048.24 ± 1735.41 6283.42 ± 2299.50 <0.0001 2.78

Abbreviations: EAD, early allograft dysfunction; lysoPC, lysophosphatidylcholines; PC, phosphatidylcholine.